Detalhe da pesquisa
1.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 436, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589856
2.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482190
3.
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data.
Liver Int
; 43(8): 1803-1812, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452505
4.
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.
Gut
; 71(7): 1277-1288, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34433583
5.
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study.
Int J Cancer
; 151(8): 1310-1320, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35723131
6.
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis.
Oncologist
; 26(4): 302-309, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336844
7.
Prognostic Impact of Primary Side and RAS/RAF Mutations in a Surgical Series of Colorectal Cancer with Peritoneal Metastases.
Ann Surg Oncol
; 28(6): 3332-3342, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974694
8.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392769
9.
A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.
Int J Cancer
; 146(12): 3495-3503, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31814120
10.
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S Trial.
Oncologist
; 25(3): e460-e468, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162808
11.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
BMC Cancer
; 24(1): 563, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711003
12.
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
BMC Cancer
; 19(1): 283, 2019 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30922323
13.
Estimating Survival Probabilities of Advanced Gastric Cancer Patients in the Second-Line Setting: The Gastric Life Nomogram.
Oncology
; 95(6): 344-352, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30130791
14.
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
Br J Cancer
; 117(3): 347-352, 2017 Jul 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654634
15.
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions.
Oncology
; 93(5): 279-286, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28881354
16.
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
J Transl Med
; 14(1): 125, 2016 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154293
17.
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase.
Int J Mol Sci
; 16(4): 8884-95, 2015 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25906475
18.
NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
JAMA Netw Open
; 7(1): e2350756, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190183
19.
Different Genomic Clusters Impact on Responses in Advanced Biliary Tract Cancer Treated with Cisplatin Plus Gemcitabine Plus Durvalumab.
Target Oncol
; 19(2): 223-235, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345693
20.
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.
Eur J Cancer
; 200: 113587, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340384